Current Molecular Pharmacology

SJR Rank #4,726H-index: 54SJR: 1.024Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

KeAi Communications Co.

Country

United Arab Emirates

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Drug DiscoveryQ1
  • PharmacologyQ1
  • Molecular MedicineQ2

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Ion channel regulation and functionMicroRNA in disease regulationNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingCancer, Lipids, and MetabolismPeroxisome Proliferator-Activated ReceptorsComputational Drug Discovery MethodsStress Responses and CortisolDiverse Scientific and Economic StudiesCancer Mechanisms and Therapy

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs065130195260

Documents per Year

20222025020406080

Detailed Information

ISSN

1874-4702, 1874-4672

SJR Best Quartile

Q1

Region

Middle East

Citations per Document (2 years)

5.53

References per Document

86.63

Coverage

2008-2025

Scope

Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology. Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.

Metrics from SCImago Journal Rank 2025. View on SCImago